Background and Purpose-To investigate the 30-day and 12-month mortality risks among hospitalized stroke patients according to compliance with guideline-based process indicators. Methods-We used data from the Second Stroke Audit and the Mortality Register of Catalonia (Spain). The audit retrospectively explored quality of stroke care based on compliance with indicators among patients discharged from all public hospitals in Catalonia in 2007; they were identified and selected through a pre-established sampling method. The magnitude of the independent association of each indicator with 30-day and 12-month mortality was assessed using logistic regression with generalized estimating equations to account for clustering of patients within hospitals. Generalized estimating equations modeling was initially restricted to patients alive Ͼ72 hours poststroke to control for confounding by severity. Analyses were also run in 3 other samples (all patients, patients alive Ͼ7 days, and patients alive Ͼ14 days). Results-Of 1767 stroke admissions in the Second Stroke Audit, 1697 patients survived Ͼ72 hours poststroke. Within this sample, the adjusted 30-day mortality risk was negatively associated with nonadherence to different indicators, of which only antithrombotics at discharge (OR, 4.3; 95% CI, 1.72-10.78) remained significant in all data sets. At 12 months, the adjusted mortality risk was negatively associated with management of hypertension (OR, 1.87; 95% CI, 1.22-2.86) and antithrombotics at discharge (OR, 2.79; 95% CI, 1.41-5.54). Both remained unchanged across different samples. Conclusions-Assessing the impact of quality of stroke care on mortality is complex and is hampered by residual confounding, particularly in the short-term. Nevertheless, this study suggests that at least a few indicators should be used to monitor quality of stroke services. (Stroke. 2012;43:1094-1100.)
D
espite recent dramatic reductions of mortality rates, stroke remains a health problem of first order. 1 In such a relevant condition, it is essential to improve health outcomes through the implementation of evidence-based interventions. In the last decade, a series of quality improvement initiatives in the field of stroke has been reported, which comprise prospective regional or countrywide qualityfocused stroke registers [2] [3] [4] and retrospective audit methodologies. 5, 6 The rationale for these quality improvement programs is that increased quality of care is associated with better outcomes, and health outcomes are fundamental in the definition of quality of care by the Institute of Medicine: "the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge." 7 Although some studies have demonstrated a relationship between hospital complexity and specialization to patient outcomes, 8 -11 little is known about the impact of quality of stroke care on outcomes measured at the individual level. The goal of the present study was to investigate potential associations of poor stroke care, as determined by noncompliance with evidence-based process indicators, with 30-day and 12-month all-cause mortality risks.
Methods

Design and Setting
The present study is based on a linkage analysis of patient-related data from the Second Stroke Audit 2007 (2SA) with data from the Mortality Register of Catalonia (MRC) 2007 and 2008. Catalonia (Spain) has a separated public health system that covers 100% of the Catalan population (7.3 million people in 2007). In 2004, the Stroke Programme, a section of the Master Plan for Diseases of the Circulatory System of the Catalan Department of Health, launched a quality improvement initiative based on an audit and feedback scheme, after development of Clinical Practice Guidelines on stroke.
So far, 2 editions of the Stroke Audit have been completed, and data collection for the third one has recently been completed.
Study Population
The patients for this study were selected from the 2SA, which explored quality of in-hospital stroke care in 2007 through retrospective reviews of medical records of consecutive stroke patients discharged either alive or dead from all acute public hospitals in Catalonia. Stroke cases were identified from the archives of participating hospitals (nϭ47) on the basis of ICD-9 diagnostic codes (431, 433.x1, 434, and 436). Patients with transient ischemic attacks and subarachnoid hemorrhages were not included. Hospitals had to produce a list based on the above mentioned diagnostics and contributed 20, 40, or 60 consecutive stroke cases according to their annual number of stroke admissions; this was shown by the Hospital Discharge Database 2007 (hospitals with Ͻ150 admissions, 20 cases; 150 -350 admissions, 40 cases; and Ͼ350 admissions, 60 cases). 6 Cases corresponded to patients discharged from January 1, 2007 onward until completion of the sample requested. The final sample of the 2SA represented approximately 16.5% of all stroke discharges that occurred in Catalonia during 2007. For this study, we used data of stroke patients alive Ͼ72 hours poststroke so as to minimize the impact of patients with very poor prognosis at onset on clinical outcomes.
Because of the retrospective nature of the design, obtaining informed consent was not necessary according to local law. The Stroke Audit protocol was approved by the Research Commission of the Catalan Agency for Health Technology Assessment and Research after assessment of confidentiality and ethical aspects. Additional methodological details are described elsewhere 12 (online-only Supplemental Methods; http://stroke.ahajournals.org, for data validation).
Stroke Quality Indicators
The 2SA assessed quality of care through a series of process indicators selected by members of the Clinical Practice Guidelines Board and the Standing Commission of the Stroke Programme, out of more than 250 recommendations included in the Clinical Practice Guidelines. The 43 indicators selected by consensus were considered to have clinical and/or scientific relevance and to represent a priori standards of stroke care. Finally, 13 of 43 indicators were selected on the grounds of representing both clinically and scientifically relevant recommendations (online-only Supplemental Data, definitions of 13 quality indicators). Because our original aim was to develop an audit tool applicable to any acute hospital within our network of public hospitals, and thrombolysis can only be delivered at designated referral hospitals within the network, the final list of quality indicators did not include the use of intravenous thrombolysis as a performance measure.
Outcome Measures
We studied the 30-day and 12-month cumulative all-cause mortality poststroke. Patient survival status was obtained through linkage of affiliation variables (name and 2 surnames [father's and mother's surnames, respectively], sex, date of birth, date of stroke, and province of residence) to the official mortality data from the MRC 2007 and 2008. For those patients who died, the MRC provided the date and cause of death (ICD-10). Survival status, date, and cause of death after hospitalization were obtained from the MRC, whereas in-hospital deaths at 12, 24, and 72 hours, and 7 days poststroke were obtained from 2SA data. In only 1 case, date of in-hospital death was obtained from the MRC. 
Statistical Analyses
We described frequencies and means for patient baseline characteristics and compared them according to 30-day and 12-month mortality using Pearson 2. Adherence to quality indicators was calculated as the number of patients with documented compliance with any given indicator in relation to the number of valid cases for the measure being evaluated. Failure to document the provision of care was considered noncompliance. We calculated mean compliance and 95% CI for each quality indicator in the study sample. We also calculated unadjusted case-fatality rates at different time points (7 days, 30 days, 3 months, 6 months, and 12 months).
To estimate the unadjusted and adjusted odds ratios of 30-day and 12-month mortality according to noncompliance with each quality indicator, we used logistic regression with generalized estimating equations (GEE) that accounted for clustering of patients within hospitals. The models were adjusted by age, sex, comorbidities (diabetes, dyslipidemia, hypertension, previous coronary heart disease, previous stroke/transient ischemic attack, peripheral vascular disease, and atrial fibrillation), prestroke independence for activities of daily living (this information was taken directly from the medical records whenever it was available and was not subject to any abstraction process), type of stroke (if the quality indicator being evaluated was applicable to both ischemic and hemorrhagic strokes), and speech disturbance, motor impairment, and ability to walk. Because baseline stroke severity measured by the National Institutes of Health Stroke Scale (NIHSS) was only recorded in 37% of patients, we used the last 3 adjustment variables, corresponding to the worst neurological impairment within first 72 hours poststroke as recorded in case notes, as proxies of stroke severity. 13, 14 The probability of confounding by disease severity and short-term prognosis was still suspected to be high, even after excluding those patients who died within the first 72 hours poststroke; therefore, we conducted additional analyses. We reproduced the same statistical models to estimate adjusted ORs in different data subsets: all patients included in the 2SA without exclusions, and progressively more restrictive samples excluding those patients dead within the first 72 hours, 7 days, and within 14 days.
All analyses were performed using STATA 11.1.
Results
Among 1767 stroke admissions included in the 2SA (corresponding to 1761 patients), 1697 patients survived Ͼ72 hours after stroke. Within the 2SA sample of patients, the 7-day, 30-day, 3-month, 6-month, and 12-month cumulative allcause case fatality rates were: 7.2%, 13.7%, 17.6%, 20.9%, and 24.8%, respectively (online-only Supplemental Data, additional information about causes of death). The 2SA in-hospital case-fatality rate was 11.4% (201 patients) and the length of stay was 8 days (median; interquartile range, 5-13 days). Mean age of the study sample was 75.1Ϯ12 years, with 47.7% being women. In 89.9% of patients, the qualifying event was ischemic stroke. According to the baseline NIHSS, available in 629 patients (37%), 61.3% of patients had a mild stroke (NIHSS Յ7), 18.6% of patients had a moderate one (NIHSS 8 -14) , and the remaining patients had a severe stroke (NIHSS Ͼ14). The baseline characteristics of the patient sample are shown in Table 1 .
Thirty-Day and 12-Month All-Cause Mortality Risks and Noncompliance With Process Indicators
Using the study sample (nϭ1697), we estimated the 30-day and 12-month mortality ORs according to noncompliance with the process indicators included in the 2SA. After adjustment, the 30-day mortality risk was significantly increased among patients with ischemic or hemorrhagic strokes who did not have a swallowing test, those not mobilized early after stroke, and those who did not have an assessment of rehabilitation needs. Furthermore, patients with ischemic strokes who did not receive antiplatelets within the first 48 hours poststroke, those without an appropriate management of dyslipidemia, and those discharged without antithrombotics also displayed increased 30-day mortality risk ( Table 2) . Three of the previous process indicators were also significantly associated with increased mortality risk at 12 months after adjustment: early mobilization, assessment of rehabilitation needs, and antithrombotics on discharge. In addition, risk-adjusted mortality at 12 months was also negatively associated with management of hypertension ( Table 2) . Because baseline stroke severity is among the strongest predictors of death, we undertook additional analyses to assess the impact of poor prognosis at stroke onset on the associations seen in the study sample. We reproduced the same statistical models in different data sets: all patients included in the 2SA without exclusions (nϭ1761), excluding those patients dead within the first 72 hours (nϭ1697), 7 days (nϭ1635), and within 14 days (nϭ1578). As for mortality risk at 30 days, and with exceptions such as noncompliance with swallowing test and early mobilization that showed no effect at all in the most restrictive sample (OR, 1.08 [95% CI, 0.56 -2.07] and OR, 0.99 [95% CI, 0.48 -2.07], respectively), most associations maintained identical directions across data sets, although some turned nonsignificant. Thus, of the 6 indicators significantly associated with 30-day mortality in the study sample, only 1 (antithrombotics on discharge) remained significant in all data sets ( Figure 1 ). As for mortality risk at 12 months (Figure 2) , early mobilization and assessment of rehabilitation needs, which had a significant effect in the study sample, lost their effect in the most restrictive sample (OR, 
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spectrum, the effect of noncompliance on management of hypertension and antithrombotics at discharge remained stable and significant across all samples.
Discussion
This study suggests that establishing associations between stroke care and mortality on the grounds of poor compliance with guideline-based recommendations is difficult and is hampered by residual confounding; this is true particularly when assessing the short-term mortality risk. However, a few process indicators seem to be associated with increased risk of death at 30 days and 12 months, and this would make them key indicators for monitoring quality of stroke services. Several publications have addressed whether quality of care, as measured with process indicators, is associated with relevant clinical outcomes in patients hospitalized with heart failure, 15, 16 (online-only Supplemental Data, additional references) or in patients with acute coronary syndromes, [17] [18] [19] (online-only Supplemental Data, additional references); however, only a few have focused on stroke patients. The Get With The Guidelines (GWTG)-stroke program recently reported on significant reductions of risk-adjusted, in-hospital mortality over time among ischemic stroke/transient ischemic attack patients enrolled in the program, along with substantial improvements in performance measures over time. 20 However, authors pointed out the need for additional studies to establish whether improvements in clinical outcomes would reflect improved stroke care. Another study, also based on data from the GWTG-stroke program, did not find evidence that differences in care quality had a measurable impact on short-term, in-hospital outcomes. 21 Authors argued that any potential association between quality of care and clinical outcomes should be established on the grounds of postdischarge outcome measures. Bravata et al, 22 using a combined outcome that included in-hospital mortality, discharge to hospice or to a skilled nursing facility, and a retrospective design, showed that screening of dysphagia, deep vein thrombosis prophylaxis, and treatment of hypoxia were independently associated with outcomes among patients with ischemic strokes. Using data from the Taiwan Stroke Registry, Hsieh et al 23 recently reported reductions in the risk of cardiovascular events and death at 1, 3, and 6 months poststroke among ischemic stroke patients who received antithrombotics at discharge or anticoagulation in case of atrial fibrillation compared with those who did not. Finally, a nationwide study undertaken in Denmark could not link the observed sex-related differences in short-term mortality with differences in acute hospital care. 24 One main problem of the current study, and the reason for the stratified analyses undertaken within different data sets, is the confounding role of disease severity. The so-called confounding by severity, a type of confounding by indication, 25 can arise in observational studies when patients with worse prognosis preferentially receive, or do not receive, a particular treatment on the basis of such prognosis. In our case, patients presenting with very severe strokes could have received only palliative care on the grounds of a very bad prognosis or could have been managed more aggressively than others with less-severe strokes. In either situation, the nihilistic or the aggressive approach, the final results would overestimate or underestimate, respectively, the potential association of poor care with mortality. We tried to minimize the confounding effect of severely ill patients by excluding those who died within first 72 hours poststroke in the study sample. Moreover, we subsequently replicated all GEE models considering different data sets defined according to no restriction at all (the complete sample of 2SA patients) or maximum restriction (after exclusion of deaths within first 14 days). With this, we wanted to investigate to what extent residual confounding was affecting the initial results. Figures  1 and 2 illustrate variations across different data sets: whereas considerable variation exists for the association of poor care with 30-day mortality risk, the ORs for the association with 12-month mortality are much more stable and robust. Figures  1 and 2 therefore suggests that although residual confounding does exist in the short-term, leading to an overestimation of the impact of poor care on 30-day mortality risk, it barely affects the associations of poor care with long-term death. Within the most restrictive sample, a few indicators seem to have a significant impact: noncompliance with antithrombotics on discharge (for 30-day and 12-month mortality risk) and with management of hypertension (for 12-month mortality risk). However, it is relevant to say that the results achieved in the most restrictive sample are not robust because of loss of power and, most importantly, because of fatalities, which makes the multivariate models unstable. In any case, and setting aside the high level of evidence that supports class I recommendations for the use of antithrombotics and antihypertensive agents in secondary prevention of stroke, 26,27 their role as key indicators (at least for antithrombotics at discharge) has also been shown by others. 23 The main goal of stroke quality improvement initiatives is to improve quality of stroke care and prevention through monitoring the adherences to guideline-based performance measures in routine clinical practice. Because guidelinebased indicators are usually supported by evidence of improved outcomes, it is pretty straightforward to say that better care, defined through estimates of compliance with these indicators, should correlate with better outcomes. However, this study adds to others in showing that proving a direct relationship between process measures and outcomes is often difficult. 16, 28, 29 Adherence to an individual measure in isolation may not have a clinically detectable impact on outcomes, making determination of an effect more difficult. 30 Furthermore, mortality is just 1 among a series of patient-centered outcomes and, thus, for the quality indicators selected, relationships might be more evident to outcomes different from mortality.
The current study has some limitations. First, the retrospective nature of this study limited the availability of prognostic factors. Particularly relevant information missed by such a design includes comorbidities other than vascular risk factors, a frailty index, neuroimaging findings, stroke severity, inhospital complications, and specific features making a particular process intervention not appropriate (for instance, an accurate identification of patients offered comfort care only). Second, our approach to the lack of baseline NIHSS scores using proxies of stroke severity is arguable. These variables, though, were collected as part of the primary audit and were not reconstructed post hoc. Third, the sampling method was based on hospitals' annual volume of stroke admissions. Thus, hospitals collected fixed samples to satisfy a preestablished number depending on their size, rather than performed sampling by a fixed time span. In small hospitals, the sample would have captured patients over a full year, whereas larger hospitals would have sampled the first few months of the year only. Because care might change over the calendar cycle, particularly because of staff replacement at teaching hospitals (which in Catalonia occurs in May and June), this sampling method could be a source of bias. However, none of the small hospitals are teaching hospitals and, thus, have permanent staff.
Conclusions
Although quality of care is a complex, multidimensional construct, and poor quality does not necessarily associate with worse survival, our study suggests that adherence to some quality indicators is associated with improved survival after stroke. Thus, indicators such as antithrombotics at discharge and management of hypertension should be routinely used to monitor clinical performance. However, some degree of residual confounding is inherent to any observational study; therefore, the challenge for future research is to assess potential confounders at the patient's bedside prospectively, and to consider other relevant patientrelated outcome variables that may be associated with the quality of stroke care, to link such information with hospital-based characteristics.
1
SUPPLEMENTAL MATERIAL
Data validation in the Second Stroke Audit
To check quality of data, all hospitals undergoing an internal data collection (n= 22) had a subsequent external audit consisting of double data collection and entry of approximately 10% of all cases, after random selection. The external monitoring focused on the core variables only (those involved in the calculation of adherences to the original 43 PMs). To carry out the monitoring, we selected a reduced set of auditors with a health care professional background (6 nurses, 2 medical documentalists, 1 health technician, and 1 general physician), whom had been specifically trained for this task. Training included a single session where the audit tool and its contents were presented to external auditors. Additionally, a users' guide with a description of each variable and its possible values, and a help line were available along the recruitment period for local collaborators and external auditors.
A total of 77 cases (9.5% of patients recruited at centers with internal data collection) were externally audited after random selection to check the quality of the data collected at each study site. The global inter-rater agreement was 0.63 (substantial agreement according to Landis & Koch).
Sources of disagreement were further investigated and found to be caused by external auditors reporting missing data. The external audit showed local data collectors provided reliable data. 1 (0.4) 11 (2.6) Total* 236 (100) 431 (100) * In 6 cases (in-hospital deaths) the cause of death based on the ICD-10 classification could not be assessed because they did not link to the MRC data.
Distribution of causes of death among patients included in the Second
